Hexarelin 5 mg

Dragon Pharma Hexarelin 5 mg

Hexarelin 5 mg by Dragon Pharma is a research growth hormone secretagogue studied for its potent effect on natural GH release. Also known as Examorelin, Hexarelin is one of the best-known peptides in the GHRP category and is often discussed in advanced protocols related to recovery, body composition, sleep quality, and GH-axis support.

Among athletes, bodybuilders, and fitness-focused users, Hexarelin is often viewed as a stronger option within the secretagogue category. Because of that reputation, it is usually researched more carefully than milder GH-related peptides. For users looking to buy Hexarelin by Dragon Pharma, product quality, sterile handling, and third-party lab transparency remain important when choosing a reliable source.

Hexarelin Composition

Hexarelin (Examorelin) is a synthetic hexapeptide in the growth hormone secretagogue class. It is commonly described as a ghrelin mimetic because it interacts with growth hormone secretagogue receptors involved in natural GH release.

Compared with other GHRPs, Hexarelin is frequently discussed for its stronger receptor activity and more pronounced GH pulse potential. That higher activity is also why many research discussions emphasize careful cycle structure and dose control.

Bodybuilding and Recovery Support

In performance-focused settings, Hexarelin is commonly researched for its relationship to growth hormone support, recovery, body composition, and sleep. Because of its stronger reputation among GH secretagogues, it is often discussed by more experienced users rather than beginners.

• Growth hormone support: studied for strong acute GH pulse activity
• Recovery support: often explored in post-training and tissue-repair focused protocols
• Sleep quality: commonly discussed in relation to overnight recovery support
• Body composition: researched for lean-mass support and fat-loss related goals
• Connective tissue support: frequently mentioned in GH-related recovery discussions
• Advanced protocol use: often researched by users with prior experience using GH secretagogues

For more background on its GH-releasing profile, you can refer to this PubMed study on Hexarelin and GH secretion.

Research Background

Hexarelin has been studied in relation to growth hormone release, recovery support, metabolic function, and aging-related GH decline. It is also discussed in some research for its cardioprotective profile, which helps distinguish it from other GHRP compounds.

Because of its strong activity, Hexarelin is often approached as a more advanced peptide in GH-oriented research protocols, particularly when users are already familiar with other secretagogues such as GHRP-2 or GHRP-6.

Dosage (Men)

Note: Hexarelin is intended for research purposes only. The following reflects common protocol patterns and your provided context rather than medical advice.

Hexarelin is commonly researched in subcutaneous protocols used 1-3 times daily, often in fasted states or before sleep. Common examples include:

• Standard Protocol: 100-200 mcg per dose, 1-3 times daily
• Pre-Bed Use: often included in night-time recovery protocols
• Cycle Structure: shorter research cycles are commonly discussed because of receptor-sensitivity concerns
• Fasted Timing: commonly used away from meals in GH-focused protocols

The 5 mg vial is commonly reconstituted with 2 mL of bacteriostatic water, creating a concentration of 2.5 mg/mL. At that concentration, a 150 mcg dose equals 0.06 mL, or 6 units on a U-100 insulin syringe, while a 200 mcg dose equals 0.08 mL.

Dosage (Women)

Female research protocols often use lower amounts, commonly in the range of 50-150 mcg per dose, usually once or twice daily depending on protocol design. As with other GH secretagogues, conservative starting doses are commonly preferred in research discussions.

Active Life

Hexarelin has a relatively short circulating half-life, but it is often discussed as having a strong and noticeable GH pulse profile after administration. Because of its higher activity, research protocols often focus not only on dosing but also on receptor management and on-off cycle structure.

Hexarelin Side Effects

Hexarelin is generally discussed as well tolerated in research settings, though stronger GH secretagogues may increase the likelihood of flushing, headache, temporary drowsiness, mild injection-site irritation, hunger changes, or hormonal side effects related to prolactin and cortisol signaling.

Because Hexarelin is often described as more potent than many comparable GHRPs, careful dose control and shorter protocol cycles are commonly emphasized.

Hexarelin Contraindications/Precautionary Measures

Hexarelin should not be used by pregnant or nursing women. Individuals with serious endocrine disorders, pituitary conditions, diabetes, prolactin-sensitive issues, or a history of growth-factor-sensitive disease should use caution when considering GH secretagogue research. Proper sterile handling and storage should always be followed. Keep out of reach of children.

Overdosage

Excessive use may increase the likelihood of headache, nausea, flushing, appetite changes, temporary hormonal side effects, or faster receptor desensitization. Because the peptide is relatively short acting, acute symptoms are generally discussed as temporary, but overly aggressive use should still be avoided.

Hexarelin Stack/Cycle

Hexarelin is often researched alongside other peptides involved in GH support and recovery-focused protocols. Common combinations include:

• CJC-1295 DAC – frequently explored for combining sustained GHRH support with stronger acute GH secretagogue activity
• GHRP-2 – commonly discussed in rotating or comparative GH-secretagogue protocols
• Sermorelin – often researched in protocols combining GHRH signaling with GHS-based support

These combinations are typically explored by users interested in recovery, body composition support, sleep quality, and more advanced GH-axis protocol design.

Package Presentation

Dragon Pharma presents Hexarelin in a sterile 2 mL vial containing 5 mg of lyophilized powder. The freeze-dried format helps preserve stability before reconstitution and supports accurate dose preparation.

Storage

Store the lyophilized vial in a cool, dry place away from direct light and moisture, ideally at 2-8°C. After reconstitution with bacteriostatic water, keep refrigerated and use within 2-3 weeks for best stability. Do not freeze.

Hexarelin Referrers

This product is intended for laboratory research and analytical purposes only. Not for human consumption. Always verify the legality of this compound in your jurisdiction before purchase.

Third-Party Lab Test Results

Dragon Pharma is committed to transparency and quality. Below are the latest third-party lab test results for Hexarelin 5 mg, verifying purity and accurate dosing.

2025-09-12

View Result

5.34 mg

Lab test conducted: 2025-09-12 | Result: 5.34 mg (106.8% of labeled dose)

Hexarelin Frequently Asked Questions